Achromatopsia As a Potential Candidate for Gene Therapy

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2010 Mar 19

PMID 20238068

Citations 18

Authors

Ji-Jing Pang

John Alexander

Bo Lei

Wentao Deng

Keqing Zhang

Qiuhong Li

Bo Chang

William W Hauswirth

Affiliations

Soon will be listed here.

Abstract

Achromatopsia is an autosomal recessive retinal disease involving loss of cone function that afflicts approximately 1 in 30,000 individuals. Patients with achromatopsia usually have visual acuities lower than 20/200 because of the central vision loss, photophobia, complete color blindness and reduced cone-mediated electroretinographic (ERG) amplitudes. Mutations in three genes have been found to be the primary causes of achromatopsia, including CNGB3 (beta subunit of the cone cyclic nucleotide-gated cation channel), CNGA3 (alpha subunit of the cone cyclic nucleotide-gated cation channel), and GNAT2 (cone specific alpha subunit of transducin). Naturally occurring mouse models with mutations in Cnga3 (cpfl5 mice) and Gnat2 (cpfl3 mice) were discovered at The Jackson Laboratory. A natural occurring canine model with CNGB3 mutations has also been found. These animal models have many of the central phenotypic features of the corresponding human diseases. Using adeno-associated virus (AAV)-mediated gene therapy, we and others show that cone function can be restored in all three models. These data suggest that human achromatopsia may be a good candidate for corrective gene therapy.

Citing Articles

Onset and Progression of Disease in Nonhuman Primates With PDE6C Cone Disorder.

Ardon M, Nguyen L, Chen R, Rogers J, Stout T, Thomasy S Invest Ophthalmol Vis Sci. 2024; 65(14):16.

PMID: 39641747 PMC: 11629912. DOI: 10.1167/iovs.65.14.16.

Update on Clinical Trial Endpoints in Gene Therapy Trials for Inherited Retinal Diseases.

Igoe J, Lam B, Gregori N J Clin Med. 2024; 13(18).

PMID: 39336999 PMC: 11431936. DOI: 10.3390/jcm13185512.

Phenotype and genotype of 15 Saudi patients with achromatopsia: A case series.

Danish E, Alhashem A, Aljehani R, Aljawi A, Aldarwish M, Al Mutairi F Saudi J Ophthalmol. 2023; 37(4):301-306.

PMID: 38155673 PMC: 10752271. DOI: 10.4103/sjopt.sjopt_108_23.

Identification of the Transcriptional Biomarkers Panel Linked to Pathological Remodelling of the Eye Tissues in Various HD Mouse Models.

Mazur-Michalek I, Rucinski M, Sowinski M, Pietras P, Lesniczak-Staszak M, Szaflarski W Cells. 2022; 11(10).

PMID: 35626712 PMC: 9139483. DOI: 10.3390/cells11101675.

The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.

Martinez Velazquez L, Ballios B Int J Mol Sci. 2021; 22(21).

PMID: 34768969 PMC: 8583900. DOI: 10.3390/ijms222111542.

References

Schiefer U, Kurtenbach A, Braun E, Kraus W, Zrenner E . Centrally tinted contact lenses. A useful visual aid for patients with achromatopsia. Ger J Ophthalmol. 1995; 4(1):52-6. View

Young R, Krefman R, Anderson R, Fishman G . Two additional benefits of dark glasses on rod vision in patients with congenital achromatopsia. Am J Optom Physiol Opt. 1983; 60(1):56-60. DOI: 10.1097/00006324-198301000-00010. View

Kohl S, Varsanyi B, Antunes G, Baumann B, Hoyng C, Jagle H . CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet. 2005; 13(3):302-8. DOI: 10.1038/sj.ejhg.5201269. View

Bradley J, Reisert J, Frings S . Regulation of cyclic nucleotide-gated channels. Curr Opin Neurobiol. 2005; 15(3):343-9. DOI: 10.1016/j.conb.2005.05.014. View

Goto-Omoto S, Hayashi T, Gekka T, Kubo A, Takeuchi T, Kitahara K . Compound heterozygous CNGA3 mutations (R436W, L633P) in a Japanese patient with congenital achromatopsia. Vis Neurosci. 2006; 23(3-4):395-402. DOI: 10.1017/S095252380623308X. View

Chang B, Dacey M, Hawes N, Hitchcock P, Milam A, Atmaca-Sonmez P . Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2. Invest Ophthalmol Vis Sci. 2006; 47(11):5017-21. DOI: 10.1167/iovs.05-1468. View

Schornack M, Brown W, Siemsen D . The use of tinted contact lenses in the management of achromatopsia. Optometry. 2007; 78(1):17-22. DOI: 10.1016/j.optm.2006.07.012. View

Alexander J, Umino Y, Everhart D, Chang B, Min S, Li Q . Restoration of cone vision in a mouse model of achromatopsia. Nat Med. 2007; 13(6):685-7. PMC: 3985124. DOI: 10.1038/nm1596. View

Khan N, Wissinger B, Kohl S, Sieving P . CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function. Invest Ophthalmol Vis Sci. 2007; 48(8):3864-71. DOI: 10.1167/iovs.06-1521. View

10.

Carroll J, Choi S, Williams D . In vivo imaging of the photoreceptor mosaic of a rod monochromat. Vision Res. 2008; 48(26):2564-8. PMC: 2582057. DOI: 10.1016/j.visres.2008.04.006. View

11.

Sundin O, Yang J, Li Y, Zhu D, Hurd J, Mitchell T . Genetic basis of total colourblindness among the Pingelapese islanders. Nat Genet. 2000; 25(3):289-93. DOI: 10.1038/77162. View

12.

Kohl S, Baumann B, Broghammer M, Jagle H, Sieving P, Kellner U . Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet. 2000; 9(14):2107-16. DOI: 10.1093/hmg/9.14.2107. View

13.

Cai K, Itoh Y, Khorana H . Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: use of a photoactivatable reagent. Proc Natl Acad Sci U S A. 2001; 98(9):4877-82. PMC: 33131. DOI: 10.1073/pnas.051632898. View

14.

Wissinger B, Gamer D, Jagle H, Giorda R, Marx T, Mayer S . CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet. 2001; 69(4):722-37. PMC: 1226059. DOI: 10.1086/323613. View

15.

Bradley J, Frings S, Yau K, REED R . Nomenclature for ion channel subunits. Science. 2002; 294(5549):2095-6. PMC: 2901924. DOI: 10.1126/science.294.5549.2095. View

16.

Kaupp U, Seifert R . Cyclic nucleotide-gated ion channels. Physiol Rev. 2002; 82(3):769-824. DOI: 10.1152/physrev.00008.2002. View

17.

Kohl S, Baumann B, Rosenberg T, Kellner U, Lorenz B, Vadala M . Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet. 2002; 71(2):422-5. PMC: 379175. DOI: 10.1086/341835. View

18.

Sidjanin D, Lowe J, McElwee J, Milne B, Phippen T, Sargan D . Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002; 11(16):1823-33. DOI: 10.1093/hmg/11.16.1823. View

19.

Aligianis I, Forshew T, Johnson S, Michaelides M, Johnson C, Trembath R . Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet. 2002; 39(9):656-60. PMC: 1735242. DOI: 10.1136/jmg.39.9.656. View

20.

Park W, Sunness J . Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol. 2004; 137(4):774-5. DOI: 10.1016/j.ajo.2003.09.061. View